CVE-2018-14787 json
In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 2.x or prior and Xcelera Version 4.1 or prior), an attacker with esca…
published 2018-08-22 8 y ago modified 2026-06-17 4 mo ago also EUVD-2018-6671
- cvss
- 7.8
- version 3.1, NVD
- cisa kev
- Not listed
- not in CISA's catalog
- epss
- 0.4%
- EPSS 0.4% chance of exploitation in 30 days, percentile 33%
- public exploits
- 0
- none known
Summary
In Philips' IntelliSpace Cardiovascular (ISCV) products (ISCV Version 2.x or prior and Xcelera Version 4.1 or prior), an attacker with escalated privileges could access folders which contain executables where authenticated users have write permissions, and could then execute arbitrary code with local administrative permissions.
Exploit prediction
0.39% chance of exploitation in the next 30 days, higher than 33% of all scored CVEs (FIRST EPSS, 2026-11-08).
CVSS scores
| assigned by | version | score | vector |
|---|---|---|---|
| NVD | 3.1 | 7.8 | CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H |
| NVD | 2.0 | 4.6 | AV:L/AC:L/Au:N/C:P/I:P/A:P |
Affected products
- Philips IntelliSpace Cardiovascular (ISCV) products
Classification
- Weakness
-
- CWE-269 Improper Privilege Management
References
-
usa.philips.com
/healthcare/about/customer-support/product-security
vendor-advisory
-
ics-cert.us-cert.gov
/advisories/ICSMA-18-226-01
third-party-advisory, us-government-resource
Sources
- CVE List CVE-2018-14787
- NVD CVE-2018-14787
Fencer Vulns keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.